Novo Nordisk Net Worth 2006-2020 | NVO

Interactive chart of historical net worth (market cap) for Novo Nordisk (NVO) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Novo Nordisk net worth as of August 11, 2020 is $152.17B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $152.167B $18.296B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $389.737B 18.57
Roche Holding AG (RHHBY) Switzerland $293.115B 0.00
Pfizer (PFE) United States $213.329B 13.33
Merck (MRK) United States $204.641B 14.60
Novartis AG (NVS) Switzerland $188.566B 14.66
AbbVie (ABBV) United States $163.035B 9.93
Eli Lilly (LLY) United States $146.340B 22.34
AstraZeneca (AZN) United Kingdom $145.338B 28.25
Sanofi (SNY) $127.486B 15.15
GlaxoSmithKline (GSK) United Kingdom $102.699B 13.47
Bayer (BAYRY) Germany $61.996B 8.94
H Lundbeck (HLUYY) Denmark $7.388B 12.84
Innoviva (INVA) United States $1.376B 6.59